Posted on 8/14/18
Optinose Reports Second Quarter 2018 Financial Results and Recent Operational Highlights
YARDLEY, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, . . .
Posted on 8/14/18
Neuronetics Reports Second Quarter 2018 Financial and Operating Results
MALVERN, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that . . .
Posted on 8/14/18
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
RUTHERFORD, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular . . .
Posted on 8/14/18
Icahn Drops Opposition To Cigna/Express Scripts Deal
Carl Icahn is dropping his opposition to the $54B takeover of Express Scripts (NASDAQ:ESRX) by Cigna (NYSE:CI).Noting that two proxy advisers had come in with support . . .
Posted on 8/14/18
Citius Closes $10M Underwritten Offering Priced At-the-Market
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the closing of the previously . . .
Posted on 8/13/18
Provention Bio Reports Second Quarter 2018 Financial Results and Provides Business Update
Recent Corporate Highlights: Closed initial public offering of common stock on July 19, 2018, generating $63.9 million in gross proceedsExpanded pipeline with two additional clinical-stage assets . . .
Posted on 8/13/18
3 Beaten-Down Biotech Stocks: Can They Recover?
It's been an outstanding year for fledgling biotechnology companies across the board, but these three haven't fared as well as the rest of their industry in . . .
Posted on 8/13/18
Vitamin Shoppe: Cognitive Dissonance And Why We Got Short When Shares Crossed $11
SummaryVitamin Shoppe's stock is on a tear after posting better than feared Q2 2018 results, but this just feels like a short squeeze.Adjusted for Nutri-Force moving . . .
Posted on 8/13/18
Why Celgene Corporation Bounced Back in July
What happenedAfter a prolonged losing streak, Celgene Corporation's (NASDAQ:CELG) stock rebounded quite nicely last month by gaining 13.4%, according to data from S&P Global Market Intelligence. . . .
Posted on 8/12/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on August 6, 2018 it approved non-statutory stock options to purchase an aggregate of 170,200 shares of its . . .
Posted on 8/10/18
Matinas BioPharma Provides Corporate Update
BEDMINSTER, N.J., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on enabling targeted intracellular delivery of . . .
Posted on 8/10/18
ADMA Biologics Reports Second Quarter 2018 Financial Results
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 10, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) today announced its financial results for the quarter ended . . .
Posted on 8/10/18
VenatoRx Pharmaceuticals Named a 2018 Best Places to Work
MALVERN, Pa.--(BUSINESS WIRE)--VenatoRx Pharmaceuticals today announced that it was named one of the “2018 Best Places to Work” in the Greater Philadelphia area by the Philadelphia . . .
Posted on 8/10/18
Post Acute Medical Enters Joint Venture with Home Health Agency
Post Acute Medical, LLC (PAM) has entered into a joint venture with Be Healthy at Home, a home health care organization based in Buda, Texas. Together, . . .
Posted on 8/9/18
Citius Announces Pricing of $10.0 Million Underwritten Offering
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced the pricing of an underwritten . . .
Posted on 8/8/18
Celldex Provides Corporate Update and Reports Q2 2018 Results
HAMPTON, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the second quarter ended June 30, 2018. . . .
Posted on 8/8/18
Strongbridge Biopharma Reports Q2 2018 Financial Results and Provides Corporate Update
DUBLIN, Ireland and TREVOSE, Pa., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and . . .
Posted on 8/8/18
Context Therapeutics Signs Strategic Research Collaborations
PHILADELPHIA--(BUSINESS WIRE)--Context Therapeutics, a clinical stage biopharmaceutical company dedicated to the treatment of hormone driven cancers, today announces it has signed multiple research collaborations to further . . .
Posted on 8/8/18
Champions Oncology Granted Full Accreditation by the AAALAC
Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced . . .
Posted on 8/8/18
Johnson & Johnson: Headline Risk But Business Solid
SummaryWe remain big fans of the steady hand displayed by the venerable Johnson & Johnson as the pharmaceutical bellwether continues to perform admirably.During its second-quarter results, . . .
Posted on 8/8/18
Pfizer: The Outlook Cannot Justify Current Valuation
SummaryPfizer is currently trading at a ~20% discount rate, when taking into account discounted cash flows as well as a multiples analysis.Current estimates of a -5% . . .
Posted on 8/7/18
Onconova Therapeutics to Provide Corporate Update
NEWTOWN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat . . .
Posted on 8/7/18
Spark Therapeutics Reports Q2 2018 Financial Results and Recent Business Progress
PHILADELPHIA, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, . . .
Posted on 8/7/18
Eagle Pharmaceuticals Reports Second Quarter 2018 Results
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today announced its financial results for the three and six months ended June 30, 2018. Highlights of and subsequent . . .
Posted on 8/7/18
Aramark Reports Record Third Quarter Results
PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE: ARMK) today reported third quarter fiscal 2018 results.“We reported record performance driven by broad-based results across the globe. Our focus on delivering an . . .

